Doxercalciferol NDC 55150-357

NDC codes

FDA NDC Directory

Product NDC (as listed)55150-357Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55150-0357Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55150-357-50	55150035750	50 CARTON in 1 CARTON (55150-357-50) / 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-357-01) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Jan 24, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Doxercalciferol
Generic name (nonproprietary): doxercalciferol
Active ingredients: Doxercalciferol — 2 ug/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Eugia US LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213717
Marketing start: Jan 24, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Ergocalciferols (Chemical structure)
Identifiers: Product ID 55150-357_211361e9-87ad-476a-af8f-8b887c3b6c4eSPL ID 211361e9-87ad-476a-af8f-8b887c3b6c4eSPL set ID 3376536b-043d-478a-b129-7ce11ec94e3eRxCUI 282609, 1790208, 1790219UNII 3DIZ9LF5Y9UPC 0355150358014, 0355150357017
Pharmacologic class: Vitamin D2 Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N455150035750 followed by a unit qualifier and the quantity

Package 55150-0357-50. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 23, 2025.

Indications (excerpt from the label)

Doxercalciferol injection is indicated for the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD) on dialysis. Doxercalciferol is a synthetic vitamin D 2 analog: Doxercalciferol injection is indicated for the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD) on dialysis. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 213717

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213717
Product	Strength	Form · route	Labeler	Product NDC
Doxercalciferol	Doxercalciferol 4 ug/2mL	Injection, SolutionIntravenous	Eugia US LLC	55150-358
Doxercalciferol	Doxercalciferol 4 ug/2mL	Injection, SolutionIntravenous	Eugia US LLC	55150-359